Th17 Cell Pathogenicity

Th17 Cell Pathogenicity is a pathogenic immune mechanism characterized by the aberrant activation and effector function of T helper 17 cells, distinguished from other T-cell-mediated pathologies by their specific production of pro-inflammatory cytokines, particularly IL-17, that drive tissue inflammation and autoimmunity.

320

Publications

37.6K

Citations

2.4K

Authors

692

Institutions

Publications per year

2017–2026

182

Authors

2.4K

  1. VK
    Vijay K. Kuchroo

    Brigham and Women's Hospital, United States

    14 publications · 10.8K citations

    13

    h-index

  2. AR
    Aviv Regev

    Broad Institute, United States

    8 publications · 3.6K citations

    8

    h-index

  3. XL
    Xiuxing Liu

    Sun Yat-sen University, China

    5 publications · 189 citations

    7

    h-index

  4. WS
    Wenru Su

    Sun Yat-sen University, China

    5 publications · 189 citations

    7

    h-index

  5. RA
    Richard A. Flavell

    Yale University, United States

    7 publications · 483 citations

    7

    h-index

1–5 of 2.4K

Venues

  1. The Journal of Immunology

    JI · 35 publications · 4K citations

    29

    h-index

  2. Nature Communications

    16 publications · 1.6K citations

    16

    h-index

  3. Frontiers in Immunology

    12 publications · 520 citations

    13

    h-index

  4. PLoS ONE

    9 publications · 706 citations

    9

    h-index

  5. Immunity

    9 publications · 1.3K citations

    9

    h-index

1–5